Study Reveals Public Opinion on Polygenic Embryo Screening for IVF
By Stephanie Dutchen,
Harvard Medical School
| 05. 14. 2024
At a glance:
Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for likelihood of developing certain health conditions or traits that arise from more than one gene.
Only about one-third of respondents approved of using the technology to predict traits unrelated to disease.
Nearly all expressed concerns about potential negative outcomes for individuals or society.
Findings underscore need for public education about benefits, limitations, ethical hazards of polygenic risk scores for embryos.
Three out of four adults in the U.S. support the use of emerging technologies that estimate a future child’s likelihood of developing certain health conditions influenced by multiple genes — such as diabetes, heart disease, and depression — before an embryo is implanted during in vitro fertilization (IVF), according to a new public opinion survey led by researchers at Harvard Medical School.
Results of the survey, published May 14 in JAMA Network Open, underscore the need for public education and conversation about the potential positive and negative implications of these ethically fraught technologies, the researchers said.
Although the approach...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...